Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2891]

ESMO 2026: New targeted therapy improved survival for patients with KRAS-mutated lung cancer

ESMO 2026: New targeted therapy improved survival for patients with KRAS-mutated lung cancer

ESMO 2026: Immunotherapy combo extends survival for patients with aggressive small cell lung cancer

ESMO 2026: Immunotherapy combo extends survival for patients with aggressive small cell lung cancer

ESMO 2026: Patients with a form of advanced lung cancer lived 56% longer without their disease progressing after receiving radiotherapy in addition to standard treatment

ESMO 2026: Patients with a form of advanced lung cancer lived 56% longer without their disease progressing after...

‘Molecular glue’ stabilises protein that inhibits development of non-small cell lung cancer and uterine cancer

‘Molecular glue’ stabilises protein that inhibits development of non-small cell lung cancer and uterine cancer

Cancer cells killed with their own carbon monoxide

Cancer cells killed with their own carbon monoxide

Researchers unlock promising lung cancer treatment option

Researchers unlock promising lung cancer treatment option

Novel blood test detects lung cancer traces long before scans

Novel blood test detects lung cancer traces long before scans

Structurally guided therapy shows promise for patients with specific EGFR-mutated lung cancer in Phase 1b trial

Structurally guided therapy shows promise for patients with specific EGFR-mutated lung cancer in Phase 1b trial

New study challenges “obesity paradox” in lung cancer, points to suppressed airway immunity

New study challenges “obesity paradox” in lung cancer, points to suppressed airway immunity

Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs

Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs

More from ecancer